ATC code M04

Template:ATC code M ATC code M04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup M04 is part of the anatomical group M Musculo-skeletal system.[3]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.[4]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

## Contents

* 1 M04A Antigout preparations
* 1.1 M04AA Preparations inhibiting uric acid production
* 1.2 M04AB Preparations increasing uric acid excretion
* 1.3 M04AC Preparations with no effect on uric acid metabolism
* 1.4 M04AX Other antigout preparations
* 2 References

## M04A Antigout preparations

### M04AA Preparations inhibiting uric acid production

M04AA01 Allopurinol
M04AA02 Tisopurine
M04AA03 Febuxostat
M04AA51 Allopurinol, combinations

### M04AB Preparations increasing uric acid excretion

M04AB01 Probenecid
M04AB02 Sulfinpyrazone
M04AB03 Benzbromarone
M04AB04 Isobromindione
M04AB05 Lesinurad
M04AB06 Dotinurad

### M04AC Preparations with no effect on uric acid metabolism

M04AC01 Colchicine
M04AC02 Cinchophen
M04AC51 Colchicine and probenecid

### M04AX Other antigout preparations

M04AX01 Urate oxidase
M04AX02 Pegloticase

## References

1. ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html. Retrieved 2020-02-01.
2. ↑ "ATC-Klassifikation mit definierten Tagesdosen DDD". German Institute for Medical Documentation and Information. https://www.dimdi.de/dynamic/de/arzneimittel/atc-klassifikation/. Retrieved 2020-02-01.
3. ↑ "ATC/DDD Index 2020: code M04". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/?code=M04.
4. ↑ "ATCvet Index 2020: code QM04". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/?code=M04.

* v
* t
* e

Drugs used for gout (M04)

Drugs to lower uric acid levels|

| primary|

* Probenecid
* Sulfinpyrazone
* Benzbromarone
* Isobromindione

|

secondary|

* Amlodipine
* Atorvastatin
* Fenofibrate
* Guaifenesin
* Lesinurad
* Losartan

Xanthine oxidase inhibitors|

| purine analogues|

* Allopurinol#
* Oxypurinol
* Tisopurine

|

other|

* Febuxostat
* Inositols (Phytic acid
* Myo-inositol)
* Topiroxostat

Mitotic inhibitors|

* Colchicine

Other|

* Cinchophen
* NSAIDs except aspirin
* Sevelamer
* Urate oxidase (Rasburicase
* Pegloticase)

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/ATC code M04. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:ATC_code_M04&oldid=4434208"
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template